Analysts’ updated eps estimates for Wednesday, April 17th:
Albertsons Companies (NYSE:ACI) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $27.25 price target on the stock.
ACV Auctions (NASDAQ:ACVA) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $19.00 price target on the stock.
AEON Biopharma (NASDAQ:AEON) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $18.00 price target on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $200.00 price target on the stock.
Ameresco (NYSE:AMRC) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings Inc..
Atlanticus (NASDAQ:ATLC) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $39.00 target price on the stock.
Boeing (NYSE:BA) was downgraded by analysts at Northcoast Research from a neutral rating to a sell rating. Northcoast Research currently has $140.00 price target on the stock.
Blink Charging (NASDAQ:BLNK) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $7.00 price target on the stock.
BioLineRx (NASDAQ:BLRX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $21.00 target price on the stock.
Barnes & Noble Education (NYSE:BNED) had its hold rating reissued by analysts at Needham & Company LLC.
BioNTech (NASDAQ:BNTX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $107.00 target price on the stock.
Calix (NYSE:CALX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $50.00 target price on the stock.
CarGurus (NASDAQ:CARG) had its market perform rating reissued by analysts at JMP Securities.
CareDx (NASDAQ:CDNA) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $15.00 target price on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $80.00 price target on the stock.
Clearfield (NASDAQ:CLFD) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $36.00 price target on the stock.
Clene (NASDAQ:CLNN) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $7.00 price target on the stock.
Clorox (NYSE:CLX) had its neutral rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $162.00 price target on the stock.
Coursera (NYSE:COUR) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $26.00 price target on the stock.
Capri (NYSE:CPRI) had its mixed rating reiterated by analysts at OTR Global.
CrowdStrike (NASDAQ:CRWD) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $400.00 price target on the stock.
Carvana (NYSE:CVNA) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $80.00 price target on the stock.
CyberArk Software (NASDAQ:CYBR) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $300.00 price target on the stock.
Daré Bioscience (NASDAQ:DARE) had its hold rating reissued by analysts at Brookline Capital Management.
Datadog (NASDAQ:DDOG) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $150.00 target price on the stock.
Precision BioSciences (NASDAQ:DTIL) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $60.00 target price on the stock.
DZS (NASDAQ:DZSI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $9.00 price target on the stock.
Encore Capital Group (NASDAQ:ECPG) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $60.00 price target on the stock.
Envestnet (NYSE:ENV) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $79.00 target price on the stock.
EQT (NYSE:EQT) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. Wells Fargo & Company currently has $37.00 price target on the stock, down from their previous price target of $48.00.
Edgewise Therapeutics (NASDAQ:EWTX) had its buy rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $25.00 price target on the stock.
FB Financial (NYSE:FBK) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $38.00 price target on the stock.
First Solar (NASDAQ:FSLR) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. They currently have a $269.00 price target on the stock.
Fortinet (NASDAQ:FTNT) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $65.00 target price on the stock.
Fortive (NYSE:FTV) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $90.00 price target on the stock, down from their previous price target of $95.00.
Fulton Financial (NASDAQ:FULT) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $16.00 target price on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $50.00 price target on the stock.
Home Depot (NYSE:HD) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $417.00 price target on the stock.
Harmonic (NASDAQ:HLIT) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $18.00 price target on the stock.
Hancock Whitney (NASDAQ:HWC) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $50.00 target price on the stock.
Hancock Whitney (NASDAQ:HWC) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $52.00 target price on the stock, down from their previous target price of $55.00.
International Business Machines (NYSE:IBM) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $190.00 target price on the stock.
Intel (NASDAQ:INTC) had its neutral rating reiterated by analysts at Wedbush. They currently have a $40.00 price target on the stock.
International Paper (NYSE:IP) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $40.00 target price on the stock.
Inter Parfums (NASDAQ:IPAR) had its buy rating reaffirmed by analysts at BWS Financial. BWS Financial currently has a $172.00 price target on the stock.
J.B. Hunt Transport Services (NASDAQ:JBHT) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $215.00 target price on the stock.
Stride (NYSE:LRN) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $75.00 price target on the stock.
LuxUrban Hotels (NASDAQ:LUXH) had its buy rating reiterated by analysts at Jonestrading. They currently have a $4.00 target price on the stock, down from their previous target price of $10.00.
Mercantile Bank (NASDAQ:MBWM) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $47.00 price target on the stock.
Marsh & McLennan Companies (NYSE:MMC) was downgraded by analysts at Piper Sandler from an overweight rating to a neutral rating. The firm currently has $211.00 price target on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its outperform rating reissued by analysts at Wedbush. They currently have a $147.00 price target on the stock.
Cloudflare (NYSE:NET) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $100.00 target price on the stock.
Netflix (NASDAQ:NFLX) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $713.00 target price on the stock, up from their previous target price of $638.00.
Nicolet Bankshares (NYSE:NIC) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $92.00 target price on the stock.
OncoCyte (NASDAQ:OCX) had its equal weight rating reiterated by analysts at Stephens. They currently have a $4.00 price target on the stock.
OneMain (NYSE:OMF) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $57.00 price target on the stock.
OppFi (NYSE:OPFI) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $5.00 target price on the stock.
Orange (NYSE:ORAN) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co..
Palo Alto Networks (NASDAQ:PANW) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $350.00 target price on the stock.
Progyny (NASDAQ:PGNY) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $46.00 price target on the stock.
The PNC Financial Services Group (NYSE:PNC) had its underperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $152.00 price target on the stock.
Quantum (NASDAQ:QMCO) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings Inc..
Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $28.00 target price on the stock.
Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reiterated by analysts at Wedbush. The firm currently has a $24.00 price target on the stock.
Sage Therapeutics (NASDAQ:SAGE) was downgraded by analysts at Bank of America Co. from a neutral rating to an underperform rating. Bank of America Co. currently has $14.00 price target on the stock, down from their previous price target of $24.00.
Sleep Number (NASDAQ:SNBR) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $13.50 price target on the stock.
Society Pass (NASDAQ:SOPA) had its hold rating reiterated by analysts at Maxim Group.
Trip.com Group (NASDAQ:TCOM) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $55.00 target price on the stock.
TScan Therapeutics (NASDAQ:TCRX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $10.00 price target on the stock.
Tapestry (NYSE:TPR) had its mixed rating reissued by analysts at OTR Global.
Tesla (NASDAQ:TSLA) had its outperform rating reiterated by analysts at Robert W. Baird. The firm currently has a $280.00 price target on the stock.
Take-Two Interactive Software (NASDAQ:TTWO) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $190.00 price target on the stock.
Travere Therapeutics (NASDAQ:TVTX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $13.00 price target on the stock.
Twilio (NYSE:TWLO) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. They currently have a $75.00 target price on the stock.
UnitedHealth Group (NYSE:UNH) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $600.00 price target on the stock.
Upstart (NASDAQ:UPST) had its market perform rating reaffirmed by analysts at JMP Securities.
Urban Outfitters (NASDAQ:URBN) was downgraded by analysts at Jefferies Financial Group Inc. from a hold rating to an underperform rating. The firm currently has $32.00 price target on the stock, down from their previous price target of $42.00.
Viracta Therapeutics (NASDAQ:VIRX) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $13.00 target price on the stock.
Vista Energy (NYSE:VIST) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. They currently have $50.00 target price on the stock, up from their previous target price of $40.00.
Volkswagen (OTCMKTS:VWAGY) was downgraded by analysts at Sanford C. Bernstein from an outperform rating to a market perform rating.
YPF Sociedad Anónima (NYSE:YPF) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. The firm currently has $24.00 price target on the stock, up from their previous price target of $20.00.
Zscaler (NASDAQ:ZS) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $230.00 price target on the stock.
Receive News & Ratings for Albertsons Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albertsons Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
